Supportive Cancer Care with Chinese Medicine

Br, Cassileth; Yeung, Kelvin

doi:10.1111/j.2042-7166.2010.01039.x

Cited by 2 publications

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Most cancer patients with a Chinese background tend to seek TCM treatment (28), which has been reported to alleviate clinical symptoms, prolong survival time and decrease the adverse effects of conventional therapy (29). The pathogenesis theory of cancerous toxins is a TCM-based theory on the differentiation and treatment of tumors (30).…”

Section: Discussionmentioning

confidence: 99%

Long‑term survival of a patient with advanced lung cancer treated with targeted therapy and anti‑PD‑1 immunotherapy as multi‑line therapy: A case report

Guo,

Zhu,

Zhao

et al. 2023

Oncol Lett

View full text Add to dashboard Cite

Lung cancer is the most common type of cancer worldwide. Lung adenocarcinoma, a type of non-small cell lung cancer (NSCLC), is a common type of lung cancer. In recent years, immunotherapy has become the primary method of treatment for several solid cancers, including NSCLC. In the present study, the case of a patient with NSCLC following left superior lobectomy is reported. Different systemic therapies failed, such as a pemetrexed + carboplatin regimen, paclitaxel liposome + cisplatin and pembrolizumab, and albumin-bound paclitaxel + toripalimab, but long-term survival was achieved following targeted therapy and anti-programmed cell death protein-1 (PD-1) immunotherapy. The patient survived for >4 years following lung cancer progression, which is notably longer than expected for patients with advanced lung cancer. In conclusion, the present case demonstrated the efficacy of targeted therapy and anti-PD-1 immunotherapy for the treatment of advanced lung cancer following the occurrence of drug resistance and progressive disease.

show abstract

Section: Discussionmentioning

confidence: 99%